New Test May Improve Diagnosis and Treatment of Pancreatic Cancers
University of Chicago Medical CenterWhen blood was collected from the portal vein from patients with suspected pancreatic or bile duct cancer, researchers found circulating tumors cells in 100 percent of 18 patients, compared to only 4 out of 18 when using standard samples.